Is ATII Stock Undervalued?

A comprehensive valuation analysis of Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII) examining current multiples, intrinsic value, and comparing to analyst expectations.

8 min readView Full Analysis

Valuation Verdict

Potentially Undervalued

1092855490.2% upside potential

Based on our analysis, Archimedes Tech SPAC Partners II Co. Ordinary Shares appears to be potentially undervalued at the current price of $11.10. Our fair value estimate of $121306970.51 suggests upside potential of approximately 1092855490.2%.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing ATII relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio
37.63
High
P/B Ratio
1.42
Moderate
P/S Ratio
N/A
EV/EBITDA
N/A

Understanding the Metrics

  • P/E Ratio: At 37.63x earnings, ATII is trading above the typical market average of 15-20x.
  • P/B Ratio: A P/B of 1.42 means investors pay $1.42 for every $1 of book value.
  • P/S Ratio: Revenue data not available.
  • EV/EBITDA: EBITDA data not available.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Archimedes Tech SPAC Partners II Co. Ordinary Shares stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price
$11.10
vs
Fair Value Estimate
$121306970.51
Implied Return+1092855490.2%

Our DCF model suggests ATII may be undervalued by approximately 1092855490.2%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.

Investment Conclusion

Bottom Line

Based on our comprehensive valuation analysis, Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII) appears to be undervalued at $11.10. With a fair value estimate of $121306970.51, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.

Compare with Peers

See how Archimedes Tech SPAC Partners II Co. Ordinary Shares stacks up against similar companies

Popular Valuation Analysis

Explore valuation analysis for top stocks